In today's edition of the Motley Fool's health-care show, Market Checkup, analysts Max Macaluso and David Williamson cover an FDA rejection for Merck, approvals for Johnson & Johnson, and a new partnership for AbbVie.

Two game-changing biotech stocks

Alison Southwick has no position in any stocks mentioned. David Williamson owns shares of Pfizer. Max Macaluso, Ph.D. owns shares of Celgene. The Motley Fool recommends Celgene. It recommends and owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.